SynthesisFrontiers in pediatrics2026
The complications of irradiation or busulfan for CAYA before hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Synthesis in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hematopoietic stem cell transplantation (HSCT) represents a curative therapeutic modality for children, adolescents, and young-adult (CAYA) patients with various life-threatening hematological malignancies and non- malignant haematological disorders. Conditioning regimens, a cornerstone of HSCT, typically involve total body irradiation (TBI) or busulfan (Bu)-based myeloablation. However, the optimal conditioning strategy for CAYA populations remains controversial, and high-quality evidence regarding long-term complications is lacking. This systematic review and meta-analysis aimed to comprehensively compare the efficacy and safety profiles of TBI and Bu-based conditioning regimens in CAYA-HSCT recipients. Methods: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, Scopus, ClinicalTrials.gov, Wanfang Data, and CNKI databases from inception to August 3, 2025. Eligible studies included prospective or retrospective cohort studies and randomized controlled trials involving CAYA patients (0-25 years) undergoing HSCT with TBI or Bu-based conditioning. Primary outcomes were overall survival (OS), event-free survival (EFS), transplant-related mortality (TRM), and relapse rate. Secondary outcomes included seven key long-term complications: growth retardation, thyroid dysfunction, hypogonadism, secondary tumors, cataracts, neurological complications, and chronic graft-vs.-host disease (cGVHD). Results: A total of 4,928 studies were identified, with 26 ultimately included in the meta-analysis. The results showed that Bu conferred survival benefits for patients with AML and cohorts comprising both malignant and non-malignant disease cases, whereas TBI yielded superior EFS and relapse-control outcomes in ALL patients. Five long-term complications (growth retardation, thyroid dysfunction, hypogonadism, secondary tumors and cataracts) occurred at significantly lower rates in the Bu group. Sex-related heterogeneity was observed for hypogonadism with higher Bu-associated risk in one female- only cohort. No significant differences were observed in neurological complications or cGVHD between the two groups. Discussion: In conclusion, conditioning-regimen selection should be individualized according to disease subtype. For ALL patients, clinicians need to balance the survival- and relapse-preventive advantages of TBI against its long-term toxic effects on children's growth, development and vital organs. For AML patients, the survival benefits of Bu-based conditioning should be weighed against sex- dependent toxic risks. Early preventive-interventional measures and adequate education for patients and guardians are essential for CAYA patients receiving TBI or Bu-based conditioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.